Open AccessShort Term Efficacy and Safety of Insulin Glargine in Type 2 Diabetes Inadequately Controlled with Single or Two Oral Agents: A Prospective, Open Label Study
Author(s) -
Ajay Aggarwal,
Roopak Wadhwa
Publication year - 2017
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2017/27649.10214
Subject(s) - medicine , insulin glargine , type 2 diabetes , type 2 diabetes mellitus , diabetes mellitus , insulin , dosing , body mass index , prospective cohort study , basal (medicine) , basal insulin , endocrinology , gastroenterology
Basal insulin is among the second line treatment options for Type 2 Diabetes Mellitus (T2DM). Efficacy and safety of basal insulin in patients of T2DM, uncontrolled with Oral Antidiabetic Agents (OAAs) remains understudied in the Indian setting.